Related Experiment Videos
Disease activity and emotional state in multiple sclerosis
Annals of Neurology
|May 1, 1983
Summary
Emotional disturbance is highly prevalent in multiple sclerosis (MS) patients, especially during exacerbations. Stable MS patients and spinal cord-injured (SCI) controls show significantly lower rates of emotional distress.
Area of Science:
- Neurology
- Psychiatry
- Clinical Psychology
Background:
- Multiple sclerosis (MS) is a chronic neurological disease affecting the central nervous system.
- Emotional disturbances are frequently observed in MS patients, impacting quality of life.
- Understanding the prevalence and nature of these disturbances is crucial for patient care.
Purpose of the Study:
- To prospectively investigate the prevalence and characteristics of emotional disturbance in multiple sclerosis (MS) patients.
- To compare emotional disturbance rates in MS patients with spinal cord-injured (SCI) controls.
- To identify factors associated with emotional disturbance in MS.
Main Methods:
- Prospective study involving 64 MS patients and 23 SCI control patients.
- Administration of the 28-item subscale General Health Questionnaire (GHQ) to assess emotional disturbance.
- Comparison of GHQ scores between MS patient subgroups (remission vs. exacerbation/progressive) and SCI controls.
Main Results:
- MS patients with acute exacerbation or progressive disease had significantly higher mean GHQ scores (15.7) compared to those in remission (4.4) (p < 0.001).
- Prevalence of emotional disturbance was 90% in exacerbating/progressing MS patients, 39% in stable MS patients, and 12% in SCI controls.
- Emotional disturbance in MS was not correlated with age, sex, disease duration, severity, or disability level.
Conclusions:
- Emotional disturbance is highly prevalent in MS, particularly during active disease phases.
- Stable MS patients and SCI controls exhibit lower rates of emotional disturbance.
- Somatic complaints, anxiety, and social dysfunction are more common than depression in remitting MS patients.